Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Dec;104(4):1038–1044. doi: 10.1111/j.1476-5381.1991.tb12546.x

Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.

C A Briggs 1, N J Pollock 1, D E Frail 1, C L Paxson 1, R F Rakowski 1, C H Kang 1, J W Kebabian 1
PMCID: PMC1908831  PMID: 1687364

Abstract

1. A cloned 5-HT1C receptor expressed in Xenopus laevis oocytes was used to characterize the action of four dopamine D1-selective benzazepines at the 5-HT1C receptor. Additionally, the apparent binding of the D1-selective benzazepines to 5-HT1C receptors was measured in the choroid plexus of the pig. 2. In voltage-clamped oocytes expressing the cloned 5-HT1C receptor, 5-hydroxytryptamine (5-HT) elicited a characteristic inward current response with an EC50 of 13 nM. SCH 23390 acted as a stereoselective agonist (or partial agonist) with an EC50 of about 550 nM. SKF 38393 (1 microM-1 mM), SKF 77434 (100 microM), and SKF 82958 (100 microM) also acted as agonists (or partial agonists) at the cloned 5-HT1C receptor. SKF 38393 was not stereoselective at the 5-HT1C receptor. 3. The response to SCH 23390 activated slowly and, although the response contained many oscillations characteristic of the activation of the phosphatidylinositol signal transduction system, SCH 23390 rarely elicited the rapid spike-like response seen routinely in response to 5-HT. However, the responses to SKF 38393, SKF 77434, and SKF 82958 were identical in appearance to the response to 5-HT, except that the responses to the benzazepines were smaller. These comparisons were made by applying both a benzazepine and 5-HT to each individual oocyte expressing the cloned 5-HT1C receptor. 4. Consistent with the responses measured in oocytes, SCH 23390 bound stereoselectively to 5-HT1C receptors in the choroid plexus of the pig (Ki = 6.3 nM), and SKF 38393 bound non-stereoselectively with lower affinity (Ki = 2.0-2.2 microM).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1038

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen P. H., Grønvald F. C., Jansen J. A. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum. Life Sci. 1985 Nov 25;37(21):1971–1983. doi: 10.1016/0024-3205(85)90028-1. [DOI] [PubMed] [Google Scholar]
  2. Berridge M. J. Inositol 1,4,5-trisphosphate-induced calcium mobilization is localized in Xenopus oocytes. Proc R Soc Lond B Biol Sci. 1989 Dec 22;238(1292):235–243. doi: 10.1098/rspb.1989.0079. [DOI] [PubMed] [Google Scholar]
  3. Billard W., Ruperto V., Crosby G., Iorio L. C., Barnett A. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci. 1984 Oct 29;35(18):1885–1893. doi: 10.1016/0024-3205(84)90540-x. [DOI] [PubMed] [Google Scholar]
  4. Bischoff S., Heinrich M., Krauss J., Sills M. A., Williams M., Vassout A. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome. J Recept Res. 1988;8(1-4):107–120. doi: 10.3109/10799898809048981. [DOI] [PubMed] [Google Scholar]
  5. Bischoff S., Heinrich M., Sonntag J. M., Krauss J. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors. Eur J Pharmacol. 1986 Oct 7;129(3):367–370. doi: 10.1016/0014-2999(86)90449-8. [DOI] [PubMed] [Google Scholar]
  6. Conn P. J., Sanders-Bush E., Hoffman B. J., Hartig P. R. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci U S A. 1986 Jun;83(11):4086–4088. doi: 10.1073/pnas.83.11.4086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Conn P. J., Sanders-Bush E. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J Pharmacol Exp Ther. 1985 Jul;234(1):195–203. [PubMed] [Google Scholar]
  8. Dawson T. M., Barone P., Sidhu A., Wamsley J. K., Chase T. N. Quantitative autoradiographic localization of D-1 dopamine receptors in the rat brain: use of the iodinated ligand [125I]SCH 23982. Neurosci Lett. 1986 Aug 4;68(3):261–266. doi: 10.1016/0304-3940(86)90499-4. [DOI] [PubMed] [Google Scholar]
  9. De Keyser J., Dierckx R., Vanderheyden P., Ebinger G., Vauquelin G. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res. 1988 Mar 8;443(1-2):77–84. doi: 10.1016/0006-8993(88)91600-9. [DOI] [PubMed] [Google Scholar]
  10. De Keyser J., Walraevens H., Convents A., Ebinger G., Vauquelin G. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes. Eur J Pharmacol. 1989 Mar 29;162(3):437–445. doi: 10.1016/0014-2999(89)90334-8. [DOI] [PubMed] [Google Scholar]
  11. Dumont J. N. Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals. J Morphol. 1972 Feb;136(2):153–179. doi: 10.1002/jmor.1051360203. [DOI] [PubMed] [Google Scholar]
  12. Felder C. C., Blecher M., Jose P. A. Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. J Biol Chem. 1989 May 25;264(15):8739–8745. [PubMed] [Google Scholar]
  13. Felder C. C., Jose P. A., Axelrod J. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. J Pharmacol Exp Ther. 1989 Jan;248(1):171–175. [PubMed] [Google Scholar]
  14. Hartig P. R. Molecular biology of 5-HT receptors. Trends Pharmacol Sci. 1989 Feb;10(2):64–69. doi: 10.1016/0165-6147(89)90080-1. [DOI] [PubMed] [Google Scholar]
  15. Hess E. J., Battaglia G., Norman A. B., Iorio L. C., Creese I. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum. Eur J Pharmacol. 1986 Feb 11;121(1):31–38. doi: 10.1016/0014-2999(86)90389-4. [DOI] [PubMed] [Google Scholar]
  16. Hicks P. E., Schoemaker H., Langer S. Z. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain. Eur J Pharmacol. 1984 Oct 15;105(3-4):339–342. doi: 10.1016/0014-2999(84)90628-9. [DOI] [PubMed] [Google Scholar]
  17. Hoffman B. J., Mezey E. Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett. 1989 Apr 24;247(2):453–462. doi: 10.1016/0014-5793(89)81390-0. [DOI] [PubMed] [Google Scholar]
  18. Hoyer D., Engel G., Kalkman H. O. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol. 1985 Nov 26;118(1-2):13–23. doi: 10.1016/0014-2999(85)90658-2. [DOI] [PubMed] [Google Scholar]
  19. Hoyer D., Karpf A. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus. Eur J Pharmacol. 1988 May 20;150(1-2):181–184. doi: 10.1016/0014-2999(88)90766-2. [DOI] [PubMed] [Google Scholar]
  20. Hoyer D. Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci. 1988 Mar;9(3):89–94. doi: 10.1016/0165-6147(88)90174-5. [DOI] [PubMed] [Google Scholar]
  21. Hoyer D., Pazos A., Probst A., Palacios J. M. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res. 1986 Jun 18;376(1):97–107. doi: 10.1016/0006-8993(86)90903-0. [DOI] [PubMed] [Google Scholar]
  22. Hoyer D., Srivatsa S., Pazos A., Engel G., Palacios J. M. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding. Neurosci Lett. 1986 Sep 12;69(3):269–274. doi: 10.1016/0304-3940(86)90492-1. [DOI] [PubMed] [Google Scholar]
  23. Hoyer D., Waeber C., Schoeffter P., Palacios J. M., Dravid A. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):252–258. doi: 10.1007/BF00173573. [DOI] [PubMed] [Google Scholar]
  24. Hyttel J. SCH 23390 - the first selective dopamine D-1 antagonist. Eur J Pharmacol. 1983 Jul 15;91(1):153–154. doi: 10.1016/0014-2999(83)90381-3. [DOI] [PubMed] [Google Scholar]
  25. Jenck F., Broekkamp C. L., Van Delft A. M. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats. Psychopharmacology (Berl) 1990;100(3):372–376. doi: 10.1007/BF02244609. [DOI] [PubMed] [Google Scholar]
  26. Julius D., MacDermott A. B., Axel R., Jessell T. M. Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science. 1988 Jul 29;241(4865):558–564. doi: 10.1126/science.3399891. [DOI] [PubMed] [Google Scholar]
  27. LaHoste G. J., Marshall J. F. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists. Behav Brain Res. 1990 May 28;38(3):233–242. doi: 10.1016/0166-4328(90)90178-h. [DOI] [PubMed] [Google Scholar]
  28. Lester H. A. Heterologous expression of excitability proteins: route to more specific drugs? Science. 1988 Aug 26;241(4869):1057–1063. doi: 10.1126/science.2457947. [DOI] [PubMed] [Google Scholar]
  29. Lübbert H., Hoffman B. J., Snutch T. P., van Dyke T., Levine A. J., Hartig P. R., Lester H. A., Davidson N. cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc Natl Acad Sci U S A. 1987 Jun;84(12):4332–4336. doi: 10.1073/pnas.84.12.4332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lübbert H., Snutch T. P., Dascal N., Lester H. A., Davidson N. Rat brain 5-HT1C receptors are encoded by a 5-6 kbase mRNA size class and are functionally expressed in injected Xenopus oocytes. J Neurosci. 1987 Apr;7(4):1159–1165. doi: 10.1523/JNEUROSCI.07-04-01159.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mahan L. C., Burch R. M., Monsma F. J., Jr, Sibley D. R. Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2196–2200. doi: 10.1073/pnas.87.6.2196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. McQuade R. D., Ford D., Duffy R. A., Chipkin R. E., Iorio L. C., Barnett A. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses. Life Sci. 1988;43(23):1861–1869. doi: 10.1016/s0024-3205(88)80003-1. [DOI] [PubMed] [Google Scholar]
  33. Mengod G., Nguyen H., Le H., Waeber C., Lübbert H., Palacios J. M. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience. 1990;35(3):577–591. doi: 10.1016/0306-4522(90)90330-7. [DOI] [PubMed] [Google Scholar]
  34. Molineaux S. M., Jessell T. M., Axel R., Julius D. 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6793–6797. doi: 10.1073/pnas.86.17.6793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Molloy A. G., Waddington J. L. Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat. Psychopharmacology (Berl) 1987;92(2):164–168. doi: 10.1007/BF00177909. [DOI] [PubMed] [Google Scholar]
  36. Nicklaus K. J., McGonigle P., Molinoff P. B. [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus. J Pharmacol Exp Ther. 1988 Oct;247(1):343–348. [PubMed] [Google Scholar]
  37. Niznik H. B., Otsuka N. Y., Dumbrille-Ross A., Grigoriadis D., Tirpak A., Seeman P. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor. J Biol Chem. 1986 Jun 25;261(18):8397–8406. [PubMed] [Google Scholar]
  38. Ohlstein E. H., Berkowitz B. A. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors. Eur J Pharmacol. 1985 Jan 22;108(2):205–208. doi: 10.1016/0014-2999(85)90728-9. [DOI] [PubMed] [Google Scholar]
  39. Parker I., Ivorra I. Localized all-or-none calcium liberation by inositol trisphosphate. Science. 1990 Nov 16;250(4983):977–979. doi: 10.1126/science.2237441. [DOI] [PubMed] [Google Scholar]
  40. Pazos A., Hoyer D., Palacios J. M. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur J Pharmacol. 1984 Nov 27;106(3):531–538. doi: 10.1016/0014-2999(84)90056-6. [DOI] [PubMed] [Google Scholar]
  41. Pazos A., Hoyer D., Palacios J. M. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol. 1984 Nov 27;106(3):539–546. doi: 10.1016/0014-2999(84)90057-8. [DOI] [PubMed] [Google Scholar]
  42. Peroutka S. J. 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. Trends Neurosci. 1988 Nov;11(11):496–500. doi: 10.1016/0166-2236(88)90011-2. [DOI] [PubMed] [Google Scholar]
  43. Peroutka S. J. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J Neurochem. 1986 Aug;47(2):529–540. doi: 10.1111/j.1471-4159.1986.tb04532.x. [DOI] [PubMed] [Google Scholar]
  44. Rubinstein J. E., Hitzemann R. J. Further evidence against the coupling of dopamine receptors to phosphoinositide hydrolysis in rat striatum. Biochem Pharmacol. 1990 Jun 15;39(12):1965–1970. doi: 10.1016/0006-2952(90)90616-s. [DOI] [PubMed] [Google Scholar]
  45. Sakai Y., Sekiguchi M., Okamoto K., Kuwano R., Takahashi Y. Dopamine receptors expressed in the Xenopus oocytes injected with bovine striatal mRNA. Brain Res Mol Brain Res. 1990 Feb;7(2):183–187. doi: 10.1016/0169-328x(90)90097-w. [DOI] [PubMed] [Google Scholar]
  46. Schmidt A. W., Peroutka S. J. 5-Hydroxytryptamine receptor "families". FASEB J. 1989 Sep;3(11):2242–2249. doi: 10.1096/fasebj.3.11.2673898. [DOI] [PubMed] [Google Scholar]
  47. Sigel E. Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J Membr Biol. 1990 Sep;117(3):201–221. doi: 10.1007/BF01868451. [DOI] [PubMed] [Google Scholar]
  48. Skarsfeldt T., Larsen J. J. SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity. Eur J Pharmacol. 1988 Apr 13;148(3):389–395. doi: 10.1016/0014-2999(88)90117-3. [DOI] [PubMed] [Google Scholar]
  49. Smith A. A., Brooker T., Brooker G. Expression of rat mRNA coding for hormone-stimulated adenylate cyclase in Xenopus oocytes. FASEB J. 1987 Nov;1(5):380–387. doi: 10.1096/fasebj.1.5.2824269. [DOI] [PubMed] [Google Scholar]
  50. Snutch T. P. The use of Xenopus oocytes to probe synaptic communication. Trends Neurosci. 1988 Jun;11(6):250–256. doi: 10.1016/0166-2236(88)90102-6. [DOI] [PubMed] [Google Scholar]
  51. Sumikawa K., Parker I., Miledi R. Messenger RNA from rat brain induces noradrenaline and dopamine receptors in Xenopus oocytes. Proc R Soc Lond B Biol Sci. 1984 Dec 22;223(1231):255–260. doi: 10.1098/rspb.1984.0093. [DOI] [PubMed] [Google Scholar]
  52. Undie A. S., Friedman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther. 1990 Jun;253(3):987–992. [PubMed] [Google Scholar]
  53. Vasilets L. A., Schmalzing G., Mädefessel K., Haase W., Schwarz W. Activation of protein kinase C by phorbol ester induces downregulation of the Na+/K(+)-ATPase in oocytes of Xenopus laevis. J Membr Biol. 1990 Nov;118(2):131–142. doi: 10.1007/BF01868470. [DOI] [PubMed] [Google Scholar]
  54. Yagaloff K. A., Hartig P. R. 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells. J Neurosci. 1985 Dec;5(12):3178–3183. doi: 10.1523/JNEUROSCI.05-12-03178.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES